CYTK
Price
$33.04
Change
-$0.12 (-0.36%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
3.96B
31 days until earnings call
IMTX
Price
$5.38
Change
-$0.05 (-0.92%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
658.8M
43 days until earnings call
Interact to see
Advertisement

CYTK vs IMTX

Header iconCYTK vs IMTX Comparison
Open Charts CYTK vs IMTXBanner chart's image
Cytokinetics
Price$33.04
Change-$0.12 (-0.36%)
Volume$20.97K
Capitalization3.96B
Immatics
Price$5.38
Change-$0.05 (-0.92%)
Volume$21.5K
Capitalization658.8M
CYTK vs IMTX Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. IMTX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (CYTK: $33.16 vs. IMTX: $5.43)
Brand notoriety: CYTK and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 130% vs. IMTX: 82%
Market capitalization -- CYTK: $3.96B vs. IMTX: $658.8M
CYTK [@Biotechnology] is valued at $3.96B. IMTX’s [@Biotechnology] market capitalization is $658.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 3 bearish.
  • IMTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than IMTX.

Price Growth

CYTK (@Biotechnology) experienced а +2.25% price change this week, while IMTX (@Biotechnology) price change was -3.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

CYTK is expected to report earnings on Jul 31, 2025.

IMTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($3.96B) has a higher market cap than IMTX($659M). IMTX YTD gains are higher at: -23.629 vs. CYTK (-29.507). IMTX has higher annual earnings (EBITDA): -4.49M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. IMTX (544M). IMTX has less debt than CYTK: IMTX (18.4M) vs CYTK (791M). IMTX has higher revenues than CYTK: IMTX (144M) vs CYTK (19.2M).
CYTKIMTXCYTK / IMTX
Capitalization3.96B659M601%
EBITDA-513.62M-4.49M11,442%
Gain YTD-29.507-23.629125%
P/E RatioN/A27.61-
Revenue19.2M144M13%
Total Cash938M544M172%
Total Debt791M18.4M4,299%
FUNDAMENTALS RATINGS
CYTK vs IMTX: Fundamental Ratings
CYTK
IMTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
10090
PRICE GROWTH RATING
1..100
6461
P/E GROWTH RATING
1..100
167
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (62) in the null industry is somewhat better than the same rating for CYTK (100) in the Biotechnology industry. This means that IMTX’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as IMTX (100) in the null industry. This means that CYTK’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (90) in the null industry is in the same range as CYTK (100) in the Biotechnology industry. This means that IMTX’s stock grew similarly to CYTK’s over the last 12 months.

IMTX's Price Growth Rating (61) in the null industry is in the same range as CYTK (64) in the Biotechnology industry. This means that IMTX’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for IMTX (67) in the null industry. This means that CYTK’s stock grew significantly faster than IMTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKIMTX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
78%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AMZY16.440.25
+1.54%
YieldMax AMZN Option Income Strategy ETF
TOGA34.480.40
+1.19%
Tremblant Global ETF
THQ18.190.15
+0.83%
abrdn Healthcare Opportunities Fund
BKLC118.270.57
+0.48%
BNY Mellon US Large Cap Core Equity ETF
YLDE52.230.05
+0.10%
Franklin ClearBridge Enhanced Inc ETF

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IMVT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-2.21%
IMVT - CYTK
48%
Loosely correlated
-1.77%
IDYA - CYTK
48%
Loosely correlated
-4.13%
KRYS - CYTK
46%
Loosely correlated
-2.60%
ROIV - CYTK
44%
Loosely correlated
-1.81%
BEAM - CYTK
43%
Loosely correlated
-1.98%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with OCUL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-2.86%
OCUL - IMTX
48%
Loosely correlated
-2.54%
KYMR - IMTX
47%
Loosely correlated
-3.48%
CRNX - IMTX
47%
Loosely correlated
-1.48%
CGON - IMTX
46%
Loosely correlated
-0.46%
RGNX - IMTX
46%
Loosely correlated
-4.11%
More